Buy or sell PrognomiQ stock pre IPO via an EquityZen fund
PrognomiQ is a biotechnology firm that develops test products to detect early disease detection through the power of multi-omics data.
About PrognomiQ Stock
PrognomiQ is a biotechnology firm that develops test products for the early detection and treatment of cancer and other complex diseases through the power of multi-omics data.
Chief Executive Officer, President & Founder
Co-Founder & Chairman
Board of Director
John E. Blume